Share on StockTwits

Sanofi SA (NYSE:SNY) major shareholder Sanofi bought 195,000 shares of the company’s stock in a transaction dated Wednesday, July 9th. The shares were purchased at an average price of $308.27 per share, for a total transaction of $60,112,650.00. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Major shareholders that own at least 10% of a company’s shares are required to disclose their sales and purchases with the SEC.

Sanofi SA (NYSE:SNY) traded down 0.08% on Friday, hitting $51.63. 806,378 shares of the company’s stock traded hands. Sanofi SA has a 1-year low of $46.95 and a 1-year high of $54.64. The stock has a 50-day moving average of $53.33 and a 200-day moving average of $51.93. The company has a market cap of $136.4 billion and a P/E ratio of 26.61.

Sanofi SA (NYSE:SNY) last issued its quarterly earnings data on Tuesday, April 29th. The company reported $0.81 earnings per share for the quarter, missing the analysts’ consensus estimate of $0.84 by $0.03. On average, analysts predict that Sanofi SA will post $3.53 earnings per share for the current fiscal year.

A number of analysts have recently weighed in on SNY shares. Analysts at Zacks reiterated a “neutral” rating on shares of Sanofi SA in a research note on Friday, June 20th. They now have a $57.00 price target on the stock. Finally, analysts at S&P Equity Research reiterated a “hold” rating on shares of Sanofi SA in a research note on Wednesday, April 30th. Seven analysts have rated the stock with a hold rating and four have assigned a buy rating to the company. The stock currently has an average rating of “Hold” and an average price target of $55.00.

Sanofi, formerly Sanofi-Aventis is a global and diversified healthcare company. The Company discovers, develops and distributes therapeutic solutions focused on patients’ needs.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.